A QSAR study on novel series of carbonic anhydrase inhibitors hCA IX-tumor-associated (hypoxia)

Medicinal Chemistry

Volumn 8, Issue 4, 2012, Pages 656-672

  Singh, Shalini ^a  

^a BAREILLY COLLEGE   (India)

Author keywords

Carbonic anhydrase inhibitor; hCA IX; PRECLAV; QSAR; Sulfonamides

Indexed keywords

ACETAZOLAMIDE; BENZENESULFONAMIDE DERIVATIVE; BRINZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IX; DICLOFENAMIDE; DORZOLAMIDE; ETHOXZOLAMIDE; INDISULAM; METHAZOLAMIDE; SULFUR ACID DERIVATIVE; TRIAZINE DERIVATIVE;

ALGORITHM; ARTICLE; CALIBRATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS SOFTWARE; DATA BASE; HUMAN; HYPOXIA; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; TUMOR; VALIDATION PROCESS;

ANTIGENS, NEOPLASM; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; CELL HYPOXIA; COMPUTER SIMULATION; HUMANS; LINEAR MODELS; MOLECULAR STRUCTURE; NEOPLASMS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84863766994     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340612801216391     Document Type: Article

References (46)

1. Supuran, C. T. Carbonic anhydrases: novel therapeutic applications for inhibitors and Activators. Nature Rev. Drug Disc., 2008, 7, 168-81.
2. Mincione, F.; Menabuoni, L.; Supuran, C. T. In Carbonic Anhydrase, its Inhibitors and Activator; Supuran, C. T.; Scozzafava, A.; Conway J. Ed.; CRC Press: Boca Raton (FL), 2004; pp. 243-54.
3. Supuran, C. T. In Carbonic Anhydrase and Modulation of Physiologic and Pathologic Process in the Organism; Puscas, I.; Ed.; Helicon Press: Timisoara (Romania), 1994; pp. 29-111.
4. Supuran, C. T.; Scozzafava, A.; Casini, A. In Carbonicanhydrase, its inhibitors and activators; Supuran, C. T.; Scozzafava, A.; Conway J. Ed.; CRC Press: Boca Raton (FL), 2004; pp. 67-147.
5. Supuran, C. T.; Scozzafava, A.; Casini, A. Carbonic anhydrase inhibitors. Med. Res. Rev., 2003, 23, 146-89.
6. Singh, S. & Supuran CT. QSARs on human carbonic anhydrase VA and VB inhibitors of some new not yet synthesized, substituted aromatic/heterocyclic sulphonamides as anti obesity agent J. Enzyme Inhib. Med. Chem., 2011, doi: 10.3109/14756366. 2011.606544.
7. Singh, S. A comparative molecular field (CoMFA) studies on carbonic anhydrase inhibitor hCA IX-tumor-associated (hypoxia). Lett. Drug Des. Discov., 2011, 8, 877-83.
8. Khadikar, P. V.; Supuran, C. T.; Manikpuri, A. D.; Singh, S.; and Lakhwani, M. Quantitative Structure-Activity Relationship (QSAR) studies of carbonic anhydrase inhibitors and activators. J. Indian Chem. Soc., 2011, 88, 25-85.
9. Singh, J.; Singh, S.; Mishra, R.; Khadikar, P. V.; Supuran, C. T.; Brain, W. C.; and Lakhwani, M. Estimation of human carbonic anhydrase II inhibition using topological indices and their combination with quantum-theoretical descriptors. Med. Chem. 2008, 4, 30-66.
10. Tarko, L.; Supuran, C. T. QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides. Bioorg. & Med. Chem., 2007, 15, 5666-71.
11. Singh, S.; Khadikar, P. V.; Scozzafava, A.; Supuran, C. T. QSAR studies for the inhibition of the trans membrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software. J. Enzyme Inhib. Med. Chem., 2009, 24, 337-49.
12. Singh, J.; Shaik, B.; Singh, S.; Sikhima, S.; Agrawal, V. K.; Khadikar, P. V.; Supuran, C. T. QSAR studies on the activation of the human carbonic anhydrase cytosolic isoforoms I and II and secretory isozyme VI with amino acids and amines, Bioorg. Med. Chem. 2007, 15, 6501-09.
13. Korkolopoulou, P.; Perdiki, M.; Thymara, I.; Boviatsis, E.; Agrogiannis, G.; Kotsiakis, X.; Angelidakis, D.; Rologis, D.; Diamantopoulou, K.; Thomas-Tsagli, E.; Kaklamanis, L.; Gatter, K.; Patsouris, E. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX. Hum. Pathol., 2007, 38, 629-38.
14. Pacheco-Torres, J.; Lopez-Larrubia, P.; Ballesteros, P.; Cerdan, S. Imaging tumor hypoxia by magnetic resonance methods. NMR in Biomedicine, 2010, doi:10.1002/nbm.1558
15. Krohn, K. A.; Link, J. M.; Mason, R. P. Molecular Imaging of Hypoxia. J. Nucl. Med., 2008, 49(suppl.), 129-48.
16. Avni, R.; Cohen, B.; Neeman, M. Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis. NMR in Biomedicine, 2011, doi: 10.1002/nbm.1632
17. Giatromanolaki, A.; Koukourakis, M. I.; Sivridis, E.; Pastorek, J.; Wykoff, C. C.; Gatter, K. C.; Harris, A. L. Expression of Hypoxiainducible Carbonic Anhydrase-9 Relates to Angiogenic Pathways and Independently to Poor Outcome in Non-Small Cell Lung Cancer. Cancer Res., 2001, 61, 7992-98.
18. Chia, S. K.; Wykoff, C. C.; Watson, P. H.; Han, C.; Leek, R. D.; Pastorek, J.; Gatter, K. C.; Ratcliffe, P.; Harris, A. L. Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma. J. Clin. Oncol., 2001, 19, 3660-68.
19. Scozzafava, A.; Owa, T.; Mastrolorenzo, A.; Supuran, C. T. Anticancer and Antiviral Sulfonamides. Curr. Med. Chem., 2003, 10, 925-53.
20. (a) Pastorekova, S.; Pastorek, J. In Carbonic Anhydrase-Its Inhibitors and Activators; Supuran C. T. Scozzafava A. Conway J., Ed., CRC Press: Boca Raton (FL), 2004, pp. 255-81.
21. (b) Pastorekova, S.; Parkkila, S.; Pastorek J.; Supuran C. T. Carbonic Anhydrase Isozymes. J. Enzyme Inhib. Med. Chem., 2004, 19, 199-229.
22. (c) Svastova, E.; Hulikova, A.; Rafajova, M.; Zatovicova, M.; Gibadulinova, A.; Casini, A.; Cecchi, A.; Scozzafava, A.; Supuran, C. T.; Pastorek, J.; Pastorekova, S. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 2004, 577, 439-45.
23. (a) Wykoff, C. C.; Beasley, N. J.; Watson, P. H.; Turner, K. J.; Pastorek, J.; Sibtain, A.; Wilson, G. D.; Turley, H.; Talks, K. L.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J.; Harris, A. L. Hypoxiainducible Expression of Tumor-associated Carbonic Anhydrases. Cancer Res., 2000, 60, 7075-83
24. (b) Potter, C. P. S.; Harris, A. L. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br. J. Cancer. 2003, 89, 2-7.
25. Robertson, N.; Potter, C.; Harris, A. L. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer, Res., 2004, 64, 6160-65.
26. Thiry, A.; Dogne, J. M.; Masereel, B.; Supuran, C. T. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol. Sci. 2006, 27, 566-73.
27. Winum, J.-Y.; Rami, M.; Scozzafava, A.; Montero, J.-L.; Supuran, C. T. Therapeutic applications of glycosidic carbonic anhydrase inhibitors. Med. Res. Rev., 2009, 29, 419-35.
28. Saini, L.; Gupta, S. P.; and Satuluri Kumar, V. S. A. A QSAR study on some series of sodium and potassium channel blockers. Med. Chem., 2009, 5, 570-76.
29. Garaj, V.; Puccetti, L.; Fasolis, G.; Winum, J.-Y.; Montero, J.-L.; Scozzafava, A.; Vullo, D.; Innocentia, A.; Supurana, C. T. Carbonic anhydrase inhibitors: Novel sulfonamides incorporating 1, 3, 5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX Bioorg. Med. Chem. Lett., 2005, 15, 3102-08.
30. Winum, J.-Y.; Innocenti, A.; Vullo, D.; Montero, J.-L.; Supuran, C. T. Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II. Bioorg. Med. Chem. Lett., 2009, 19, 5082-85.
31. Saczewski, F.; Innocenti, A.; Sławinski, J.; Kornicka, A.; Brzozowski, Z.; Pomarnacka, E.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with Ssubstituted 4-chloro-2-mercapto-5- methyl-benzene sulfonamide. Bioorg. Med. Chem., 2008, 16, 3933-40.
32. Carta, F.; Maresca A.; Scozzafava, A.; Vullo, D.; Supuran, C. T. Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potentand selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II. Bioorg. Med. Chem., 2009, 17, 7093-99.
33. HyperChem Software7.52, HyperCube Inc. Florida Science and Technology Park, 1115 N. W. 4th street Gainesvilla Florida, 326001, USA; 2006
34. Allinger, N. L. Conformational analysis 130 MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms. J. Am. Chem. Soc. 1977, 99, 8127-34.
35. Allinger, N. L.; Yuh, Y. H. Quantam chemistry program exchange, Bloomington, Indiana Program No. 395 In Molecular Mechanics, Burkert, U. and Allinger, N. L. Ed.; ACS Monograph 177, Washington D. C., 1982.
36. Stewart J. J. P. MOPAC2009, Stewart Computational Chemistry, Colorado Springs, CO, USA, http://OpenMOPAC.net, 2008.
37. Tarko, L. Calcule QSPR/QSAR cu ajutorul programului PRECLAV. Rev. Chim. (Bucuresti), 2005, 56, 639.
38. Tarko, L.; Lupescu, I.; Groposila-Constantinescu, D. Sweetness power QSARs by PRECLAV software. ARKIVOC, 2005, x, 254-71.
39. The PRECLAV v. 1011 program is available from the Center of Organic Chemistry (CCO) - Romanian Academy; Bucharest, Romania, 2010.
40. Talete srl, DRAGON Plus for windos software for molecular descriptor calculations version 5.5, Milano, Italy, http:/www.tate.mi.it/, 2007.
41. Tarko, L., QSAR studies regarding the inhibition of the carbonic anhydrase by the sulfonamides containing a picolinoyl Group. Rev. Chim. (Bucuresti), 2007, 58, 191-94.
42. Singh, S. Comparative QSAR studies on the novel series of thiazolones and tetrazole derivatives as HCV NS5B polymerase allosteric inhibitors. Lett. Drug Des. Discov., 2009, 6, 286-97.
43. Singh, S.; Singh, S.; Shukla, P. Modeling of novel HIV-1 protease inhibitors incorporating N-Aryl-oxazolidinone-5-carboxamides as P2 ligands using quantum chemical and topological finger print descriptors. Med. Chem. Res., 2010, doi: 10.1007/s00044-010-9416-0.
44. Tarko, L. A procedure for virtual fragmentation of molecules into functiona groups. ARKIVOC, 2004, xiv, 74-82.
45. Everitt B, Landau S, Leese M. Cluster Analysis. Arnold Press: London, 2001.
46. Shannon, C. E. & Weaver, W. The Mathematical Theory of Communication. University of Illinois Press: Urbana (IL), 1949.